Company Announcements

Half Year Trading Update

Source: RNS
RNS Number : 6889C
Oxford Instruments PLC
13 October 2022


Oxford Instruments plc

Half Year Trading Update - 13 October 2022


In line with constant currency expectations for the full year


Oxford Instruments plc, a global provider of high technology products and services to many of the world's leading companies and scientific research communities, is today issuing a trading update for the half year ended 30 September 2022.


We have made good progress in the first half of the financial year, with continued strong demand for our products and services.  On a constant currency basis, orders were ahead of revenue during the period and ahead of orders for the first half of last year. On a reported basis we expect strong revenue and adjusted operating profit1 growth for the first six months of the year, supported by a currency tailwind. Constant currency growth has been tempered in the first half by global supply chain challenges, as well as price rises not yet offsetting inflationary pressures due to phasing of the order book.


The business continues to see good order growth as we address cost inflation through active price management. We continue to invest in the business to drive future growth, including new product development, as well as enhancements to operational delivery and service to support our growing business.


Our pipeline remains robust across all our end markets. We anticipate higher production in the second half, combined with the positive impact of recent price increases as we convert our record order book. This provides good visibility for an expected improvement in trading in the second half, with full year trading at constant currency remaining in line with expectations.


Our balance sheet remains strong. Excluding leases, our net cash on 30 September 2022 was approximately £94m, up from £86m on 31 March 2022.


Oxford Instruments' results for the half year ending 30 September 2022 will be released on 8 November 2022.





1.     adjusted operating profit is before amortisation and impairment of acquired intangible assets, acquisition items, and the mark-to-market revaluation of financial derivatives




Oxford Instruments plc                                                          Tel:  01865 393200

Ian Barkshire, Group Chief Executive

Gavin Hill, Chief Financial Officer

Julian Wais, Head of Investor Relations


MHP Communications                                                           Tel:  020 3128 8100

Katie Hunt/Eleni Menikou/Veronica Farah



- Ends -

Issued for and on behalf of Oxford Instruments plc


Notes to Editors  


About Oxford Instruments plc


Notes to Editors  

About Oxford Instruments plc

Oxford Instruments designs, supplies and supports high-technology products and systems which allow the world's leading companies and scientific research communities to image, analyse and manipulate materials down to the atomic and molecular level. The Group's products and services help its customers to accelerate R&D, increase manufacturing productivity and make ground-breaking discoveries across its key market segments: Semiconductor & Communications, Advanced Materials, Healthcare & Life Science, Energy & Environment and Quantum Technology.


Innovation is the driving force behind Oxford Instruments' growth and success, supporting its core purpose to enable a greener, healthier, more connected advanced society. Founded in 1959 as the first technology business to be spun out from Oxford University, Oxford Instruments is now a global company listed on the FTSE250 index of the London Stock Exchange (OXIG). Its customer-centric, market-focused strategy creates competitive advantage through understanding the technical and commercial challenges in markets with long-term structural growth drivers.


For more information, visit








This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.